Racheal Jappert
About Racheal Jappert
Racheal Jappert is an Associate Scientist at Bristol Myers Squibb in Seattle, specializing in gene editing and delivery using CRISPR/CAS9 technology.
Current Roles at Bristol Myers Squibb
Racheal Jappert is currently working as an Associate Scientist at Bristol Myers Squibb in Seattle, Washington, United States. She has been with the company since June 2021. In this role, she is involved in various aspects of scientific research, focusing on gene editing and delivery using CRISPR/CAS9 technology.
Previous Experience at Juno Therapeutics
Racheal Jappert previously worked at Juno Therapeutics, Inc. as a Research Associate from 2019 to 2020. During her 8 months at Juno Therapeutics in Seattle, Washington, she was involved in gene editing projects. Her work focused on advancing technologies related to CRISPR/CAS9, contributing to the company's ongoing research in gene therapy and immunotherapy.
Research Positions at University of Washington
Racheal Jappert has held multiple research positions at the University of Washington. From 2016 to 2019, she worked as a Research Scientist in the Greater Seattle Area. Before that, she was a Researcher in the Pharmacology Department's Wang Lab from 2014 to 2016. Her initial research experience was as an Undergraduate Researcher from 2011 to 2013, where she worked on various projects related to cellular and molecular biology.
Educational Background
Racheal Jappert holds a Bachelor of Science in Cellular, Molecular, and Developmental Biology from the University of Washington, where she studied from 2011 to 2015. She also attended Oak Harbor High School from 2007 to 2011. Her educational background laid a strong foundation for her expertise in gene editing and molecular biology.
Specialization in CRISPR/CAS9 Technology
Racheal Jappert specializes in gene editing and delivery using CRISPR/CAS9 technology. She has applied this expertise in her roles at both Juno Therapeutics and Bristol Myers Squibb. This specialization is a critical component of her contributions to the fields of gene therapy and molecular biology.